Sign inJoin waitlistJoin the waitlist

SB

Susan Bal

Physician · UAB Heersink School of Medicine

Credentials: · · · · ·

History

UAB Heersink School of Medicine
2019–Present

Hematology
2015–2016
Internal Medicine
Kettering Medical Center
2012–2015
BHARATI VIDYAPEETH'S MED COLL, PUNE UNIV, PUNE, MAHARASHTRA, INDIA
2006–2010

Research

Daratumumab, Carfilzomib, Lenalidomide, and Dexamethasone With Minimal Residual Disease Response-Adapted Therapy in Newly Diagnosed Multiple Myeloma
Journal of Clinical Oncology · 2022 · 224 citations
Minimal residual disease response-adapted therapy in newly diagnosed multiple myeloma (MASTER): final report of the multicentre, single-arm, phase 2 trial
The Lancet Haematology · 2023 · 148 citations
International harmonization in performing and reporting minimal residual disease assessment in multiple myeloma trials
Review · Leukemia · 2021 · 107 citations

Luciano Costa
49 papers
Kelly Godby
29 papers
Smith Giri
27 papers · 1 as a fellow
Natalie Callander
18 papers
Gayathri Ravi
16 papers
Bhagirathbhai Dholaria
15 papers
Binod Dhakal
14 papers
RS
Rebecca Silbermann
14 papers
EM
Eva Medvedova
12 papers
Saurabh Chhabra
11 papers
RC
Robert Cornell
8 papers
Tim Schmidt
8 papers

Clinical trials

Study of BMS-986453 in Newly Diagnosed Multiple Myeloma
Principal investigator · Recruiting · Phase 1
Susan Bal
2026–2041
Minimal Residual Disease Response-adapted Deferral of Transplant in Dysproteinemia (MILESTONE)
Principal investigator · Recruiting · Phase 2
University of Alabama at Birmingham
2021–2028
Screening for AL Amyloidosis in Smoldering Multiple Myeloma
Site PI · Recruiting
Tufts Medical Center
2024–2029